Compare Bank Maspion Indonesia Tbk. (BMAS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Maspion Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp474 (market cap 8.53T, 3.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is the larger of the two by market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 3.4K). Which is the better fit depends on your goals.
| BMAS | TSPC | |
|---|---|---|
Market Cap | 8.53T | 11.36T |
Volume | 3.4K | 1.77M |
Lot | 34 | 17.71K |
Turnover | 1.61M | 4.61B |
Average Price | 473.94 | 2,603.9 |
Value | 1.61M | 4.61B |
Indicative Equilibrium Price | — | 2,590 |
Indicative Equilibrium Volume | — | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Maspion Indonesia Tbk.
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
